Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA clears Linnaeus' IND for phase I/II trial of LNS-8801 in advanced cancer

Sep. 25, 2019

Incyte identifies PI3Kgamma inhibitors

Sep. 25, 2019

Constellation begins phase I/II trial of CPI-0209 in advanced solid tumors

Sep. 25, 2019

Pediatric phase III trial of dasiglucagon for severe hypoglycemia meets primary endpoint

Sep. 25, 2019

Reaction Biology prepares and tests HDAC inhibitors

Sep. 25, 2019

Inflazome reports new NLRP3 inflammasome inhibitors

Sep. 25, 2019

Novartis patent details HBsAg secretion inhibitors

Sep. 25, 2019

Bristol-Myers Squibb patents FPR1 and FPR2 agonists

Sep. 25, 2019

Novel mouse model of pancreatic cancer-induced cachexia mimicking human features

Sep. 25, 2019

Synthesis and evaluation of a novel radiolabeled peptide targeting GnRH receptor for prostate cancer

Sep. 25, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...